BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 32619692)

  • 1. Medical idioms for clinical Bayesian network development.
    Kyrimi E; Neves MR; McLachlan S; Neil M; Marsh W; Fenton N
    J Biomed Inform; 2020 Aug; 108():103495. PubMed ID: 32619692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A general structure for legal arguments about evidence using Bayesian networks.
    Fenton N; Neil M; Lagnado DA
    Cogn Sci; 2013; 37(1):61-102. PubMed ID: 23110576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing Bayesian networks from a dependency-layered ontology: A proof-of-concept in radiation oncology.
    Kalet AM; Doctor JN; Gennari JH; Phillips MH
    Med Phys; 2017 Aug; 44(8):4350-4359. PubMed ID: 28500765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tutorial of the probabilistic methods Bayesian networks and influence diagrams applied to medicine.
    Nistal-Nuño B
    J Evid Based Med; 2018 May; 11(2):112-124. PubMed ID: 29878581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BARD: A Structured Technique for Group Elicitation of Bayesian Networks to Support Analytic Reasoning.
    Nyberg EP; Nicholson AE; Korb KB; Wybrow M; Zukerman I; Mascaro S; Thakur S; Oshni Alvandi A; Riley J; Pearson R; Morris S; Herrmann M; Azad AKM; Bolger F; Hahn U; Lagnado D
    Risk Anal; 2022 Jun; 42(6):1155-1178. PubMed ID: 34146433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "This Is What We Don't Know": Treating Epistemic Uncertainty in Bayesian Networks for Risk Assessment.
    Sahlin U; Helle I; Perepolkin D
    Integr Environ Assess Manag; 2021 Jan; 17(1):221-232. PubMed ID: 33151017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive scoping review of Bayesian networks in healthcare: Past, present and future.
    Kyrimi E; McLachlan S; Dube K; Neves MR; Fahmi A; Fenton N
    Artif Intell Med; 2021 Jul; 117():102108. PubMed ID: 34127238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Explanation of Bayesian networks and influence diagrams in Elvira.
    Lacave C; Luque M; Díez FJ
    IEEE Trans Syst Man Cybern B Cybern; 2007 Aug; 37(4):952-65. PubMed ID: 17702292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian network modeling: A case study of an epidemiologic system analysis of cardiovascular risk.
    Fuster-Parra P; Tauler P; Bennasar-Veny M; Ligęza A; López-González AA; Aguiló A
    Comput Methods Programs Biomed; 2016 Apr; 126():128-42. PubMed ID: 26777431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian Networks for Risk Prediction Using Real-World Data: A Tool for Precision Medicine.
    Arora P; Boyne D; Slater JJ; Gupta A; Brenner DR; Druzdzel MJ
    Value Health; 2019 Apr; 22(4):439-445. PubMed ID: 30975395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analyzing the Simonshaven Case Using Bayesian Networks.
    Fenton N; Neil M; Yet B; Lagnado D
    Top Cogn Sci; 2020 Oct; 12(4):1092-1114. PubMed ID: 30861325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EXPLORING THE REPRODUCIBILITY OF PROBABILISTIC CAUSAL MOLECULAR NETWORK MODELS.
    Cohain A; Divaraniya AA; Zhu K; Scarpa JR; Kasarskis A; Zhu J; Chang R; Dudley JT; Schadt EE
    Pac Symp Biocomput; 2017; 22():120-131. PubMed ID: 27896968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian networks in healthcare: Distribution by medical condition.
    McLachlan S; Dube K; Hitman GA; Fenton NE; Kyrimi E
    Artif Intell Med; 2020 Jul; 107():101912. PubMed ID: 32828451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian Network Applications for Sustainable Holistic Water Resources Management: Modeling Opportunities for South Africa.
    Govender IH; Sahlin U; O'Brien GC
    Risk Anal; 2022 Jun; 42(6):1346-1364. PubMed ID: 34342043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inference in multiply sectioned Bayesian networks: methods and performance comparison.
    Xiang Y; Jensen FV; Chen X
    IEEE Trans Syst Man Cybern B Cybern; 2006 Jun; 36(3):546-58. PubMed ID: 16761809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From complex questionnaire and interviewing data to intelligent Bayesian network models for medical decision support.
    Constantinou AC; Fenton N; Marsh W; Radlinski L
    Artif Intell Med; 2016 Feb; 67():75-93. PubMed ID: 26830286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Building Bayesian Networks from Causal Rules.
    Sedki K; Tsopra R
    Stud Health Technol Inform; 2018; 247():740-744. PubMed ID: 29678059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A general approach to Bayesian networks for the interpretation of evidence.
    Taroni F; Biedermann A; Garbolino P; Aitken CG
    Forensic Sci Int; 2004 Jan; 139(1):5-16. PubMed ID: 14687767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling COVID-19 disease processes by remote elicitation of causal Bayesian networks from medical experts.
    Mascaro S; Wu Y; Woodberry O; Nyberg EP; Pearson R; Ramsay JA; Mace AO; Foley DA; Snelling TL; Nicholson AE;
    BMC Med Res Methodol; 2023 Mar; 23(1):76. PubMed ID: 36991342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative evaluation of reverse engineering gene regulatory networks with relevance networks, graphical gaussian models and bayesian networks.
    Werhli AV; Grzegorczyk M; Husmeier D
    Bioinformatics; 2006 Oct; 22(20):2523-31. PubMed ID: 16844710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.